Official ESCRS | European Society of Cataract & Refractive Surgeons
Copenhagen 2016 Registration Programme Exhibitor Information Virtual Exhibition Satellite Meetings Glaucoma Day 2016 Hotel Star Alliance
title

10 - 14 Sept. 2016, Bella Center, Copenhagen, Denmark

This Meeting has been awarded 27 CME credits

 

escrs app advert yo advert

Long-term results of SMILE for myopic anisometropia in children, safety and impact on visual acuity

Search Title by author or title

Session Details

Session Title: SMILE: Small Intrastromal Lenticule Extraction I

Session Date/Time: Sunday 11/09/2016 | 08:00-10:00

Paper Time: 08:18

Venue: Hall H1

First Author: : O.Ibrahim EGYPT

Co Author(s): :    M. Ibrahim   M. Sabry   A. Said              

Abstract Details

Purpose:

To evaluate the safety and efficacy of Small incision refractive lenticule extraction for treatment of pediatric high myopic anisometropia and contact lens(CL) intolerance in 18 children.

Setting:

roaya vision centers Alexandria Egypt

Methods:

The prospective, noncomparative interventional case series comprised 18 eyes of 18 children aged 5 to 12 years with high myopic anisometropia and amblyopia who were unable to use CL and glasses. SMILE was performed with sedation or general anesthesia., surgery was followed by a half-day patching of the dominant eye. Main outocome measures were cycloplegic refraction, , visual acuity (UCVA, BSCVA., topographic stability and binocular vision outcome over one year follow up.

Results:

The mean preop. spherical equivalent (SE) refraction was -9.96 diopters (D) and the mean postop. SE -1.48 D. The mean preop UCVA 0.03 increased to 0.58 postop. The mean preop. BSCVA was 0.56 and changed to 0.72 postop. All the eyes had no line lost in BSCVA, 8 eyes had one line gained, 4 and 6 eyes had two and three lines gained, resp. All eyes showed topographic stability.

Conclusions:

SMILE is effective and safe methods which may reduce high myopic anisometropia, improve visual acuity and binocular vision in children when CL intolerance.

Financial Disclosure:

... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented

Back to previous